American Renal Associates Holdings, Inc (NYSE:ARA) – Research analysts at SunTrust Banks upped their FY2017 EPS estimates for shares of American Renal Associates Holdings in a report issued on Wednesday. SunTrust Banks analyst D. Macdonald now forecasts that the company will post earnings of $0.58 per share for the year, up from their previous estimate of $0.57. SunTrust Banks also issued estimates for American Renal Associates Holdings’ Q4 2017 earnings at $0.20 EPS, Q2 2018 earnings at $0.18 EPS, Q3 2018 earnings at $0.19 EPS, Q4 2018 earnings at $0.22 EPS, FY2018 earnings at $0.72 EPS and FY2019 earnings at $0.84 EPS.

Several other research analysts also recently commented on ARA. Zacks Investment Research raised shares of American Renal Associates Holdings from a “sell” rating to a “hold” rating in a research note on Wednesday, May 10th. Wells Fargo & Company raised shares of American Renal Associates Holdings from a “market perform” rating to an “outperform” rating in a research note on Thursday, May 11th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating to the stock. American Renal Associates Holdings has an average rating of “Buy” and a consensus price target of $25.50.

WARNING: “FY2017 EPS Estimates for American Renal Associates Holdings, Inc (ARA) Increased by Analyst” was reported by Watch List News and is owned by of Watch List News. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://www.watchlistnews.com/fy2017-eps-estimates-for-american-renal-associates-holdings-inc-ara-increased-by-analyst/1467693.html.

American Renal Associates Holdings (NYSE:ARA) opened at 15.40 on Thursday. The firm has a 50 day moving average of $17.63 and a 200-day moving average of $18.18. American Renal Associates Holdings has a 52-week low of $14.50 and a 52-week high of $25.42. The stock’s market cap is $477.18 million.

American Renal Associates Holdings (NYSE:ARA) last released its quarterly earnings data on Tuesday, August 8th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.12 by $0.04. American Renal Associates Holdings had a negative net margin of 1.54% and a positive return on equity of 18.26%. The firm had revenue of $185.99 million for the quarter, compared to analysts’ expectations of $188.23 million. The company’s revenue was up .2% compared to the same quarter last year.

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. State Street Corp increased its position in American Renal Associates Holdings by 6.0% in the fourth quarter. State Street Corp now owns 172,589 shares of the company’s stock valued at $3,673,000 after buying an additional 9,745 shares in the last quarter. Teachers Advisors LLC increased its position in American Renal Associates Holdings by 42.6% in the fourth quarter. Teachers Advisors LLC now owns 20,092 shares of the company’s stock valued at $428,000 after buying an additional 6,000 shares in the last quarter. AMI Asset Management Corp increased its position in American Renal Associates Holdings by 17.8% in the first quarter. AMI Asset Management Corp now owns 447,331 shares of the company’s stock valued at $7,551,000 after buying an additional 67,725 shares in the last quarter. Atria Investments LLC bought a new position in American Renal Associates Holdings during the first quarter valued at approximately $181,000. Finally, Acadian Asset Management LLC bought a new position in American Renal Associates Holdings during the first quarter valued at approximately $588,000. 90.93% of the stock is currently owned by institutional investors.

American Renal Associates Holdings Company Profile

American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.

Earnings History and Estimates for American Renal Associates Holdings (NYSE:ARA)

Receive News & Ratings for American Renal Associates Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.